Mounjaro®
Starting from £179.99/mo
Start journey Learn moreUpper stomach pain is one of the more unsettling symptoms people report on Mounjaro (tirzepatide). Some discomfort in that region is a recognised, common side effect tied to how the medicine slows gastric emptying — but upper abdominal pain can occasionally signal something that needs prompt medical attention. Knowing the difference is the decision that matters. This page walks through the key factors, based on NHS and MHRA guidance, so you can make that call clearly. Mounjaro is a prescription-only medicine; a prescriber reviews your suitability and monitors your progress throughout treatment.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Tirzepatide activates both GIP and GLP-1 receptors, two pathways involved in regulating appetite, blood sugar and gut motility. One of the ways it works is by slowing how quickly food moves from the stomach into the small intestine. That delay is part of why appetite falls — but it also means the stomach stays fuller for longer, and the upper abdomen can feel heavy, stretched or mildly crampy, particularly in the hours after eating.
Nausea is the most frequently reported GI side effect, but discomfort in the upper stomach, indigestion and reflux-type sensations sit alongside it. For most people these symptoms are most noticeable when starting treatment or after a dose increase, then gradually settle as the body adjusts over the following week or two. If you keep your pen in the fridge door and notice the pattern (symptoms tend to cluster in the few days after your weekly injection) that rhythm is itself reassuring information.
The NHS tirzepatide medicines page lists stomach discomfort, nausea, indigestion and reflux among the common side effects seen during clinical trials. Knowing this was documented in trials involving thousands of adults doesn't make the feeling pleasant, but it does help you contextualise it.
Upper stomach pain that is severe, comes on suddenly, and doesn't ease with time deserves different attention, especially if it spreads toward the middle or upper back, or is accompanied by persistent vomiting.
This combination is the classic presentation of acute pancreatitis. In January 2026 the MHRA issued a Drug Safety Update specifically for GLP-1 medicines, confirming that acute pancreatitis is a known, infrequent but serious risk. The update advises healthcare professionals (and by extension patients) to seek urgent medical help if severe, persistent abdominal pain occurs. This applies to tirzepatide as well as other medicines in the class.
Pancreatitis is rare, but it is not something to wait out. If the pain is severe enough that you're considering calling 111 or attending A&E, the right answer is to make that call. Reassurance from a page online is not a substitute for clinical assessment. You can also read more about how different types of stomach pain on Mounjaro compare in terms of likely cause and when to act.
Not every significant symptom on tirzepatide traces back to the medicine itself. Gallbladder problems (including gallstones) are associated with rapid weight loss generally, and some GLP-1 trials have noted a higher rate of gallbladder-related events compared to placebo. Upper right abdominal pain, particularly after fatty meals, can point in that direction. Describe the location precisely when speaking to a clinician.
Acid reflux and oesophageal discomfort can also register as upper stomach or lower chest pain. The slowed gastric emptying that makes tirzepatide effective at reducing appetite can also make reflux slightly more likely, especially if you eat larger portions than the medicine allows your stomach to process comfortably. Smaller, lower-fat meals often help, as does not lying down for a couple of hours after eating.
If you're unsure whether what you're experiencing is related to Mounjaro at all, our guide to stomach pain at night on Mounjaro covers the timing patterns that help distinguish reflux from other causes, and upper back pain alongside Mounjaro explains when that combination needs attention. For broader context on tirzepatide's mechanism and side-effect profile, the tirzepatide overview page covers both in full.
The practical decision tree is fairly simple. Mild to moderate upper stomach discomfort that tracks with your injection timing, settles between doses, and isn't getting progressively worse over time: monitor it, try smaller meals, and mention it at your next clinical review. That kind of symptom usually improves as your body adapts, and your prescriber can slow the titration schedule if it doesn't.
Severe pain, pain that is worsening rather than settling, or pain combined with back radiation or vomiting that won't stop: don't wait for your scheduled review. Contact 111, your GP, or attend A&E depending on how severe it is. Tell the clinical team you are taking tirzepatide. Our full guide to Mounjaro stomach pain walks through the range of sensations people report and how to describe them clearly to a clinician.
Reporting suspected side effects through the MHRA's Yellow Card scheme is also open to patients, and submissions help the regulator monitor safety signals across the population. You can report even if you're unsure whether the symptom is connected to the medicine.
If you haven't yet started treatment and are weighing up what to expect, or if you're experiencing symptoms on a treatment you obtained elsewhere and want a fresh clinical review, you can start a free consultation with our prescribers. A real clinician reads every consultation the same day, not a decision algorithm. Mounjaro is a prescription-only medicine, and suitability is always assessed individually. It is also worth knowing that some people notice stomach pain after stopping Mounjaro, which our dedicated page covers in detail. Our clinical team's approach is explained further on the clinical team profile page.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.